The War on Drugswhich was largely fueled by discriminatory policies surrounding federal drug prohibition for the past centuryhad his fair share of Spread of racial discrimination.
The same Drug laws were also closely tied to the Drug Enforcement Administration’s roots (DEA), officials at the agency recently confirmed.
The Federal Office for Narcotics (FBN), the predecessor of the DEA, was established in 1930 by the Treasury Department to implement these laws.
However, the “The public’s view of addiction has changed over time,” said the DEA museum historian during the recent installment of his “Stories from the Collection” video series, Marijuana Moment reported.
“Increasing non-medical use — as well as racial, ethnic, and class prejudices — impacted public opinion,” the official said said. “What was a medical condition became deviant or criminal. This shift led to a wave of anti-heroin, marijuana and cocaine laws.”
Quiet, Federal ban remains a significant obstacle, although cannabis is still part of the Narcotics Act along with other substances with a high potential for abuse. However, the mood seems to be changing DEA began 2022 by approving two cannabis companies to harvest marijuana for research earlier this year. The move, which marked the end of a five-decade federal monopoly, sought to address the growing evidence of marijuana’s medical potential.
What about psychedelics?
However, the same cannot be said for other substances such as psychedelics, which have been shown to have medicinal benefits in many conditions.
Actually DEA said They plan to make Schedule 1’s list even longer by adding five more psychedelic drugs. On the other hand, the Food and Drug Administration is actively promoting research into psilocybin and MDMA as psychedelic startups attract billions of dollars in investment.
Photo: Courtesy of Kindel Media by Pexels
